Treatment: protocol designed to evaluate one or more interventions for treating a disease,
Conditions
Interventions
experimental study consist of 86 patients,
admit to our hospital,
who will treat with subcutaneous heparin injection. Purposive sampling technique will utilized,
and a form of McGill pain intensity questionnaire will use to measure pain severity. All the subjects will receive heparin twice for 10 s. They will also inject twice with heparin infusion,
though this time,
it will for 30 s. The interval between the two injections will 24 h and after each injection,
the pain intensity will measured
Active Comparator Drug
Subcutaneous heparin injection
Sponsors
Mashhad university of medical sciences
Mashhad university of medical sciences
Eligibility
Sex/Gender
Male
Age
40 Years to 69 Years
Inclusion criteria
Inclusion criteria: The study population consist of all patients, admit to the Cardiology Department of Ghaem Hospital, who receive subcutaneous heparin injection. The sample size was calculated as eighty six The patients who met the following criteria will include in the study: 1) subcutaneous heparin prescription (5,000 units per 1 mL, every 12 h ) by a physician, 2) full consciousness
Exclusion criteria
Exclusion criteria: pain and disease (such as blood coagulation, hepatic impairment, renal failure, nervous and sensory impairment in the injection site, spinal injury, diabetes, and vascular disorders, smoking or drug abuse, use of warfarin or phenobarbital, pain-relief interventions or use of analgesic medicines, redness, swelling, and bruising at the injection site, willingness to participate in the study. interventional study or registry) during the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Readmission to the hospital one year number | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of bruising one year number | — |
Countries
iran
Contacts
Public Contactmostafa ahmadi
birjand university of medical
Outcome results
None listed